Higher ALDH expression was also detected in all of the CD133+ NSCLC-derived CSCs (Figure 4C) as compared to the CD133− (non-CSCs), suggesting that the population may have greater chemoresistant characteristics [118]. This evidence concerns the gene PROM1 and non-small cell lung carcinoma.